116 related articles for article (PubMed ID: 2294391)
21. [Residual mediastinal masses after radiotherapy for Hodgkin's disease (author's transl)].
Katz M; Piekarski JD; Bayle-Weisgerber C; Laval-Jeantet M; Teillet F
Ann Radiol (Paris); 1977 Oct; 20(7):667-72. PubMed ID: 931338
[No Abstract] [Full Text] [Related]
22. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
[TBL] [Abstract][Full Text] [Related]
23. Radiotherapeutic management of Hodgkin's disease involving the mediastinum.
Fuller LM; Jing BS; Shullenberger CC; Butler JJ
Proc R Soc Med; 1967 Aug; 60(8):740-2. PubMed ID: 6035395
[No Abstract] [Full Text] [Related]
24. The significance of the residual mediastinal mass in treated Hodgkin's disease.
Jochelson M; Mauch P; Balikian J; Rosenthal D; Canellos G
J Clin Oncol; 1985 May; 3(5):637-40. PubMed ID: 3998780
[TBL] [Abstract][Full Text] [Related]
25. Massive mediastinal Hodgkin's disease with calcification masquerading teratocarcinoma: differentiation by computed tomography.
Shin MS; Branscomb BV; Ho KJ
J Comput Tomogr; 1985 Oct; 9(4):321-7. PubMed ID: 4053660
[TBL] [Abstract][Full Text] [Related]
26. [Value of endoscopic ultrasound examination of the mediastinum in Hodgkin's and non-Hodgkin's lymphomas].
Zimmer T; Patan M; Berdel WE; Dulce MC; Riecken EO
Ultraschall Med; 1997 Apr; 18(2):67-71. PubMed ID: 9304199
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of mediastinal involvement in Hodgkin's disease treated with curative radiotherapy.
Lee CK; Bloomfield CD; Goldman AI; Levitt SH
Cancer; 1980 Dec; 46(11):2403-9. PubMed ID: 7438015
[TBL] [Abstract][Full Text] [Related]
28. Stage II Hodgkin's disease. Significance of mediastinal and nonmediastinal presentations.
Fuller LM; Gamble JF; Ibrahim E; Jing BS; Butler JJ; Shullenberger CC
Radiology; 1973 Nov; 109(2):429-32. PubMed ID: 4742328
[No Abstract] [Full Text] [Related]
29. Response during radiotherapy may be associated with outcome in mediastinal Hodgkin's disease.
Movsas B; Barrows MC; Steinberg SM; Middleton LP; Okunieff P; Jaffe ES; Epstein AH
Radiat Oncol Investig; 1998; 6(5):216-25. PubMed ID: 9822168
[TBL] [Abstract][Full Text] [Related]
30. Comparison of two repositioning devices used during radiation therapy for Hodgkin's disease.
Bentel GC; Marks LB; Krishnamurthy R; Prosnitz LR
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):791-5. PubMed ID: 9240648
[TBL] [Abstract][Full Text] [Related]
31. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?
Girinsky T; Pichenot C; Beaudre A; Ghalibafian M; Lefkopoulos D
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):218-26. PubMed ID: 16169675
[TBL] [Abstract][Full Text] [Related]
32. The management of stage II Hodgkin's disease with a large mediastinal mass: a prospective program emphasizing irradiation.
Hoppe RT
Int J Radiat Oncol Biol Phys; 1985 Feb; 11(2):349-55. PubMed ID: 3972653
[TBL] [Abstract][Full Text] [Related]
33. Comparison of passive-beam proton therapy, helical tomotherapy and 3D conformal radiation therapy in Hodgkin's lymphoma female patients receiving involved-field or involved site radiation therapy.
Horn S; Fournier-Bidoz N; Pernin V; Peurien D; Vaillant M; Dendale R; Fourquet A; Kirova YM
Cancer Radiother; 2016 Apr; 20(2):98-103. PubMed ID: 26992750
[TBL] [Abstract][Full Text] [Related]
34. The significance of mediastinal involvement in early stage Hodgkin's disease.
Mauch P; Goodman R; Hellman S
Cancer; 1978 Sep; 42(3):1039-45. PubMed ID: 698907
[TBL] [Abstract][Full Text] [Related]
35. The reliability and value of determining mediastinal involvement and width on chest radiographs in patients with Hodgkin's disease.
Erdkamp FL; Houben MJ; Breed WP; Schouten HC; Wesseling FH; Jurgens FJ; Blijham GH
Eur J Radiol; 1993 Feb; 16(2):143-6. PubMed ID: 8462579
[TBL] [Abstract][Full Text] [Related]
36. [Radiotherapy of Hodgkin's disease with extensive mediastinal involvement].
Michels T; Güttler CA; Czempiel H
Strahlenther Onkol; 1986 Feb; 162(2):88-92. PubMed ID: 3952645
[TBL] [Abstract][Full Text] [Related]
37. The prognostic significance of mediastinal bulk in patients with stage IA-IVB Hodgkin's disease: a report from the Manchester Lymphoma Group.
Anderson H; Jenkins JP; Brigg DJ; Deakin DP; Palmer MK; Todd ID; Crowther D
Clin Radiol; 1985 Sep; 36(5):449-54. PubMed ID: 4075707
[TBL] [Abstract][Full Text] [Related]
38. Mantle planning: report of the Australasian Radiation Oncology Lymphoma Group film survey and consensus guidelines.
Barton MB; Rose A; Lonergan D; Thornton D; O'Brien P; Trotter G
Australas Radiol; 2000 Nov; 44(4):433-8. PubMed ID: 11103543
[TBL] [Abstract][Full Text] [Related]
39. A technique using parallel-opposed high energy electron beams for reirradiation of tumors near the spinal cord.
Gosselin M; Podgorsak EB; Evans MD; Pla M; Shenouda G
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1207-14. PubMed ID: 8262849
[TBL] [Abstract][Full Text] [Related]
40. Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease.
Devizzi L; Maffioli L; Bonfante V; Viviani S; Balzarini L; Gasparini M; Valagussa P; Bombardieri E; Santoro A; Bonadonna G
Ann Oncol; 1997; 8 Suppl 1():53-6. PubMed ID: 9187430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
